Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference

Affiliations

• ¹ Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
• ² Laboratori de Citogenètica Molecular Servei de Patologia Hospital del Mar, Barcelona, Spain Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Program, IMIM-Hospital del Mar, Barcelona, Spain.
• ³ Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
• ⁴ AP-HP, Pitie-Salpetriere Hospital, Department of Hematology, and UPMC Univ Paris 06, UMRS 1138, France.
• ⁵ Department of Haematology, Royal Bournemouth Hospital, UK.
• ⁶ Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
• ⁷ Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
• ⁸ Hospital Universitari Vall d'Hebron, Barcelona, Spain.
• ⁹ Consorcio Hospital General Universitario de Valencia, Spain.
• ¹⁰ Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
• ¹¹ Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital GeransTrias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
• ¹² Hospital Universitario Central de Asturias, Oviedo, Spain.
• ¹³ Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
• ¹⁴ Cancer Sciences, Faculty of Medicine, University of Southampton, UK.
• ¹⁵ Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden Institute of Applied Biosciences, CERTH, Thessaloniki, Greece kostas.stamatopoulos@gmail.com.